List of Figures
Hyperalgesia Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Hyperalgesia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Hyperalgesia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Hyperalgesia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 9
Hyperalgesia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
Hyperalgesia Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
Hyperalgesia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 13
Proportion of Hyperalgesia to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 14
Hyperalgesia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Hyperalgesia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Hyperalgesia to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 17
Hyperalgesia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Hyperalgesia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
Hyperalgesia Therapeutics, Global, Clinical Trials by Phase (%), 2017* 20
Hyperalgesia Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 21
Hyperalgesia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
Hyperalgesia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
Hyperalgesia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
Hyperalgesia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 25
Hyperalgesia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
Hyperalgesia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
Hyperalgesia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28
GlobalData Methodology 98


List of Tables
Hyperalgesia Therapeutics, Global, Clinical Trials by Region, 2017* 6
Hyperalgesia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Hyperalgesia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Hyperalgesia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 9
Hyperalgesia Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
Hyperalgesia Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
Hyperalgesia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
Hyperalgesia Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
Proportion of Hyperalgesia to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 14
Hyperalgesia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Hyperalgesia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Hyperalgesia to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 17
Hyperalgesia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Hyperalgesia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
Hyperalgesia Therapeutics, Global, Clinical Trials by Phase, 2017* 20
Hyperalgesia Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
Hyperalgesia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
Hyperalgesia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
Hyperalgesia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
Hyperalgesia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
Hyperalgesia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
Hyperalgesia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
Hyperalgesia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28